Safety and Efficacy of Lip Injections With Emervel Lips and Juvederm Ultra Smile

NCT01745250 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2022-08-25

No results posted yet for this study

Summary

The purpose of this study is to demonstrate the efficacy and safety of Emervel Lips and Juvederm Ultra smile

Conditions

  • Local Tolerability After Lip Filler Injections

Interventions

DEVICE

Emervel Lips

Lip treatment of both upper and lower lip

DEVICE

Juvederm Ultra Smile

Lip treatment of both upper and lower lip

Sponsors & Collaborators

  • Galderma R&D

    lead INDUSTRY

Principal Investigators

  • Said Hilton, MD · Medical Skin Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-12-31
Primary Completion
2013-07-31
Completion
2013-07-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01745250 on ClinicalTrials.gov